Chondros Dimitrios 4
4 · HALOZYME THERAPEUTICS INC · Filed Feb 14, 2019
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Award
Option to Purchase Common Stock
2019-02-12+71,602→ 71,602 totalExercise: $16.65From: 2020-02-12Exp: 2029-02-12→ Common Stock (71,602 underlying) - Award
Restricted Stock Units
2019-02-12+37,538→ 37,538 totalExercise: $0.00From: 2020-02-12→ Common Stock (37,538 underlying)
Footnotes (2)
- [F1]This option vests one-fourth on such date and then 1/48th monthly thereafter.
- [F2]This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.